Yasuo Hozumi

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Cornelis JH van de Velde, Daniel Rea, Caroline Seynaeve et al. · The Lancet · 2011 · 377 citations

Medicine, Oncology, Pharmacology +15

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Naoki Niikura, Naoki Hayashi, Norikazu Masuda et al. · Breast Cancer Research and Treatment · 2014 · 199 citations

Medicine, Oncology, Surgery +14

Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study

Masakazu Toi, Saya Hirota, Ai Tomotaki et al. · Current Nutrition & Food Science · 2013 · 130 citations · Full text

Public Health, Nutritional Sciences, Preventive Medicine +17

Effect of Tamoxifen on Serum Lipid Metabolism

Yasuo Hozumi, Mikihiko Kawano, Tsuyoshi Saito et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 105 citations

Life Sciences, Endocrinology, Oncology +17